C

Perspective Therapeutics
D

CATX

2.86000
USD
-0.02
(-0.69%)
Post Trading·2.88500USD+0.02500(+0.87%)
حجم التداول
457,062
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
326,473,756
المقالات
المزيد

العنوان: Perspective Therapeutics

القطاع: الرعاية الصحية
الصناعة: Medical Devices
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotopeLead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.